Table 3.
Clinicopathologic features and survival in fibrolamellar carcinoma (figures in parenthesis reflect percentages)
| Factor | n (%) | Overall survival (mo) | P value |
| Age (yr) | |||
| < 40 | 16 (73) | 86 | |
| ≥ 40 | 6 (27) | 72 | 0.4 |
| Gender | |||
| Female | 11 (50) | 84 | |
| Male | 11 (50) | 79 | 0.6 |
| Tumor size (cm) | |||
| < 10 | 8 (36) | 82 | |
| ≥ 10 | 14 (64) | 76 | 0.3 |
| Number | |||
| 1 | 19 (86) | 89 | |
| > 1 | 3 (14) | 77 | 0.2 |
| Hepatic resection | |||
| Hepatectomy | 16 (73) | 86 | |
| Extended hepatectomy | 4 (18) | 77 | |
| Localized resection | 2 (9) | 79 | 0.62 |
| Nodal metastases | |||
| Negative | 18 (82) | 88 | |
| Positive | 4 (18) | 78 | 0.09 |
| Vascular invasion | |||
| Absent | 17 (77) | 92 | |
| Present | 5 (23) | 58 | 0.03 |
| Safety margin | |||
| Negative | 20 (91) | 87 | |
| Positive | 2 (9) | 72 | 0.08 |